• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从培养的大鼠前列腺腺癌细胞中提取纤溶酶原激活剂及其性质

Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.

作者信息

Strickland D K, de Serrano V S, Chan S Y, Pollard M, Castellino F J

出版信息

Biochemistry. 1983 Sep 13;22(19):4444-9. doi: 10.1021/bi00288a015.

DOI:10.1021/bi00288a015
PMID:6684952
Abstract

Zymographic analysis of the supernates from confluent cultures of a rat prostate adenocarcinoma cell line, PA-III, revealed the existence of two molecular forms of specific plasminogen activators, one of molecular weight of approximately 80 000 and another of approximate molecular weight of 45 000, in sodium dodecyl sulfate. The low molecular weight form has been purified 364-fold in 66% yield from the culture medium by a combination of gel filtration on Sephacryl S-200 and affinity chromatography on Sepharose 4B-benzamidine. The purified material possessed a specific activity of 192 000 urokinase CTA units mg-1. This enzyme displayed activity toward human Glu1-plasminogen, characterized by a Km of 1.7 +/- 0.2 microM and a Vmax of 0.53 +/- 0.1 pmol of plasmin min-1 unit-1. A synthetic chromogenic substrate, H-D-Ile-Pro-Arg-p-nitroanilide (S-2288), was found for the activator. The enzyme possessed a Km of 0.33 mM and a kcat of 55 s-1 for S-2288. The activator was found to be a serine protease, inhibited by diisopropyl fluorophosphate (iPr2PF). At a concentration of 1 mM iPr2PF, and 30 nM enzyme, the half-time of this inhibition was 3.8 min. The 45 000 molecular weight enzyme was found to be inhibited by rabbit antibodies to human urokinase, thus characterizing the activator as a member of the urokinase class. The 80 000 molecular weight enzyme was not neutralized by anti-human urokinase but was neutralized by rabbit anti-human melanoma activator, likely allowing it to be classified as the tissue activator type.

摘要

对大鼠前列腺腺癌细胞系PA - III汇合培养物的上清液进行酶谱分析,结果显示在十二烷基硫酸钠中存在两种特定纤溶酶原激活剂的分子形式,一种分子量约为80000,另一种分子量约为45000。通过在Sephacryl S - 200上进行凝胶过滤和在Sepharose 4B - 苯甲脒上进行亲和层析相结合的方法,已从培养基中以66%的产率将低分子量形式纯化了364倍。纯化后的物质具有192000尿激酶CTA单位mg-1的比活性。该酶对人Glu1 - 纤溶酶原具有活性,其特征在于Km为1.7±0.2 microM,Vmax为0.53±0.1 pmol纤溶酶min-1单位-1。发现一种合成显色底物H - D - Ile - Pro - Arg - p - 硝基苯胺(S - 2288)可用于该激活剂。该酶对S - 2288的Km为0.33 mM,kcat为55 s-1。发现该激活剂是一种丝氨酸蛋白酶,可被二异丙基氟磷酸酯(iPr2PF)抑制。在1 mM iPr2PF和30 nM酶的浓度下,这种抑制的半衰期为3.8分钟。发现45000分子量的酶被抗人尿激酶的兔抗体抑制,因此将该激活剂鉴定为尿激酶类的成员。80000分子量的酶未被抗人尿激酶中和,但被兔抗人黑色素瘤激活剂中和,这可能使其被归类为组织激活剂类型。

相似文献

1
Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.从培养的大鼠前列腺腺癌细胞中提取纤溶酶原激活剂及其性质
Biochemistry. 1983 Sep 13;22(19):4444-9. doi: 10.1021/bi00288a015.
2
Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.从人细胞培养物中纯化和鉴定单链尿激酶型纤溶酶原激活剂
J Biol Chem. 1986 Jan 25;261(3):1274-8.
3
Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.从培养的人内皮细胞中分离并鉴定出一种与尿激酶无法区分的尿激酶型纤溶酶原激活剂(分子量=54,000)。
J Biol Chem. 1984 Jun 10;259(11):7198-205.
4
Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.来自增生性和恶性前列腺组织的纤溶酶原激活剂的分离与鉴定
Biochim Biophys Acta. 1984 Feb 14;797(2):256-65. doi: 10.1016/0304-4165(84)90129-6.
5
Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.组织型纤溶酶原激活剂手指结构域与截短的单链尿激酶型纤溶酶原激活剂的重组融合蛋白的特性分析
J Biol Chem. 1987 Aug 25;262(24):11779-84.
6
Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.传代培养的人脐静脉内皮细胞产生的单链尿激酶型纤溶酶原激活物的纯化及性质
J Biol Chem. 1988 Oct 15;263(29):15139-45.
7
Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator.重组单链尿激酶型纤溶酶原激活剂低分子量形式(包含Leu144至Leu411)的生化及溶栓特性
J Biol Chem. 1988 Apr 25;263(12):5594-8.
8
Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.单链尿激酶原的蛋白水解切割会诱导构象变化,这种变化发生在酶原激活以及其对纤维蛋白的高亲和力降低之后。
J Biol Chem. 1985 Oct 5;260(22):12377-81.
9
Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.在刺激尿激酶型蛋白合成和/或释放的情况下,尿激酶在正常人类受试者肠道中的转运。
J Clin Invest. 1985 Apr;75(4):1212-22. doi: 10.1172/JCI111818.
10
Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.从大鼠吉田腹水肉瘤中分离纯化纤溶酶原激活剂。
Indian J Biochem Biophys. 1991 Feb;28(1):46-51.

引用本文的文献

1
Increased activity of plasminogen activators during involution of the rat ventral prostate.大鼠腹侧前列腺 involution 过程中纤溶酶原激活剂活性增加。 (注:“involution”在医学语境中可能有“退化”“复旧”等意思,这里结合前列腺的情况,可能是指其在特定阶段的某种生理变化过程,但仅从给定文本无法准确判断其确切含义,所以直接保留英文未翻译)
Biochem J. 1984 Jul 1;221(1):171-8. doi: 10.1042/bj2210171.